Topical application of Cassia fistula L. fruit gel in management of cutaneous lesions of pemphigus vulgaris: A double-blind, placebo-controlled clinical trial

Publish Year: 1397
نوع سند: مقاله ژورنالی
زبان: English
View: 478

This Paper With 9 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_AJP-8-6_009

تاریخ نمایه سازی: 18 تیر 1398

Abstract:

Objective: Cassia fistula L. fruit extract has been traditionally used in the treatment of pemphigus vulgaris (PV) lesions in Iran. The aim of this study was to determine the efficacy of C. fistula fruit gel on healing time of PV lesions in a clinical setting.Materials and Methods: This was a randomized, double-blind placebo-controlled clinical trial that was performed in dermatology ward at Saadi hospital, affiliated to Shiraz University of Medical Sciences, Shiraz, Iran. Right- or left- sided lesions of PV patients on standard systemic treatment were randomized for treatment with either C. fistula fruit gel or placebo prescribed twice daily. The largest diameter of each lesion was measured at the baseline (day 0) and on days 10 and 20. Epithelialization Index (EI), as outcome measure was calculated and compared between the two groups.Results: The present study comprised 20 patients, with overall 82 cutaneous lesions including 41 lesions in the C. fistula fruit gel group and 41 lesions in the placebo group. The EI in the C. fistula fruit gel group was significantly higher than that of the placebo group both on day 10 (65±28vs 30±34; p=0.001) and at the end of the study (91±22 vs 69±49; p=0.003). Conclusion: Topical application of C. fistula fruit gel can be considered as an effective adjuvant therapy in treatment of PV.

Authors

Fatemh Atarzadeh

Department of Traditional Persian Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran Department of Traditional Iranian Medicine, School of Traditional Medicine, Tehran University of Medical Sciences, Tehran, Iran

Mohammad Kamalinejad

School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Gholam Amin

Department of Pharmacognosy and Department of Traditional Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Ali Salehi

Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Abida O, Mansour RB, Gargouri B, Ayed MB, Masmoudi A, ...
  • Aghili Khorasani shirazi MH. 1388. Makhzan Al-Aladvieh (The Storehouse of ...
  • Ahmed AR. 2001. Intravenous immunoglobulin therapy in the treatment of ...
  • Amini M, Kherad M, Mehrabani D, Azarpira N, Panjehshahin M, ...
  • Anhalt GJ, Dı́az LA. 2004. Pemphigus vulgaris—A model for cutaneous ...
  • Anwikar S, Bhitre M. 2010. Study of the synergistic anti-inflammatory ...
  • Atarzadeh F, Heydari M, Sanaye MR. 2016a. Avicenna- Apioneer in ...
  • Atarzadeh F, Nimruzi M, Amin G. 2016b. Blistering disease in ...
  • Atarzadeh F, Daneshfard B, Dastgheib L, Jaladat AM, Amin G. ...
  • Atarzadeh F, Jaladat A, Dastgheib L, Amin G, Nimrouzi M, ...
  • Atarzadeh F, Jaladat Am, Daneshfard B, Dastgheib L, Kamalinejad M, ...
  • Ayyanar M, Ignacimuthu S. 2009. Herbal medicines for wound healing ...
  • Bahorun T, Neergheen VS, Aruoma OI. 2004. Phytochemical constituents of ...
  • Bhalodia NR, Nariya PB, Acharya R, Shukla V. 2012. In ...
  • Bruckner-Tuderman L, Stanley J. 2008. Disorders of epidermal and dermal-cohesion ...
  • Bystryn JC, Rudolph JL. 2005. Pemphigus. Lancet, 366:61–73. ...
  • Calebotta A, Sáenz AM, González F, Carvalho M, Castillo R. ...
  • Fernández MA, Heras B, Garcia MD, Sáenz MT, Villar A. ...
  • Guo M-Z, Li X-S, Xu H-R, Mei Z-C, Shen W, ...
  • Heydari M, Homayouni K, Hashempur MH, Shams M. 2015a. Topical ...
  • Heydari M, Hashempur MH, Dalfardi B, Borhani-Haghighi A. 2015b. The ...
  • IbnSina (avecinna) H. 1037. Al-Qanoon Fit-Tib (Principles in medicine). Reprinted ...
  • Iraji F, Asilian A, Siadat AH. 2010a. Pimecrolimus 1% cream ...
  • Iraji F, Banan L. 2010b. The efficacy of nicotinamide gel ...
  • Jaffary F, Moradi SH, Nilforoushzadeh MA, Darakhshan R, Ansari N. ...
  • Jaffary F, Nilforoushzadeh MA, Ansari N, Rahimi M. 2010. Treatment ...
  • Jaladat AM, Atarzadeh F, Rezaeizadeh H, Mofid B, Mosalaie A, ...
  • Kershenovich R, Hodak E, Mimouni D. 2014. Diagnosis and classification ...
  • Kumar MS, Sripriya R, Raghavan HV, Sehgal K. 2006. Wound ...
  • Lee CK, Lee PH, Kuo YH. 2001.The chemical constituents from ...
  • Longo D, Fauci A, Kesper D, Jamson J, Hauser SLJ, ...
  • Mortazavi H, Dowlati Y, Dowlati B. 2001. A brief history ...
  • Rajagopal P, Premaletha K, Kiron S, Sreejith K. 2013. Phytochemical ...
  • Reguiai Z, Tabary T, Maizières M, Bernard P. 2012. Rituximab ...
  • Rizvi MMA, Irshad M, Hassadi GE, Younis SB. 2009. Bioefficacies ...
  • Ruocco E, Wolf R, Ruocco V, Brunetti G, Romano F, ...
  • Sadik CD, Sezin T, Kim ND. 2013. Leukotrienes orchestrating allergic ...
  • Saleem M. 2009. Lupeol, a novel anti-inflammatory and anti-cancer dietary ...
  • Siddique HR, Saleem M. 2011. Beneficial health effects of lupeol ...
  • Skowron F, Dalle S, Marcilly M, Balme B, Thomas L. ...
  • Tabrizi M, Chams‐Davatchi C, Esmaeeli N, Noormohammadpoor P, Safar F, ...
  • Thirumal M, Srimanthula S, Kishore G. 2012. Cassia fistula Linn-Pharmacognostical, ...
  • Tunakābunī MD. 2007. Tuhfat al-mu’minīn. pp 109, 590. Tehran, Nashre ...
  • Tsang SW, Zhang H, Lin C, Xiao H, Wong M, ...
  • نمایش کامل مراجع